@aiprognosis publication in IEEE Internet of Things Magazine on wearable sensor-based assessment of rest tremor and dyskinesia in Parkinson’s disease.
ieeexplore.ieee.org/document…
#ParkinsonsDisease #WearableSensors #AI
@aiprognosis publication in IEEE Internet of Things Magazine on wearable sensor-based assessment of rest tremor and dyskinesia in Parkinson’s disease.
ieeexplore.ieee.org/document…
#ParkinsonsDisease #WearableSensors #AI
New @aiprognosis publication in IEEE Internet of Things Magazine on wearable sensor-based assessment of rest tremor and dyskinesia in Parkinson’s disease.
ieeexplore.ieee.org/document…
#ParkinsonsDisease #WearableSensors #AI
New @aiprognosis publication in IEEE Internet of Things Magazine on wearable sensor-based assessment of rest tremor and dyskinesia in Parkinson’s disease.
ieeexplore.ieee.org/document…
#ParkinsonsDisease #WearableSensors #AI
@aiprognosis research presented at IEEE BSN 2026 Nikos Grammalidis (CERTH) presented “Clustering-Constrained Attention Learning for Wearable-Based Rest Tremor Assessment” in Porto.
🔗 openreview.net/pdf?id=Ab4lms…
#BSN2026 #ParkinsonsDisease #DigitalHealth
📌 @aiprognosis research presented at IEEE BSN 2026
Nikos Grammalidis (CERTH) presented “Clustering-Constrained Attention Learning for Wearable-Based Rest Tremor Assessment” in Porto.
🔗 openreview.net/pdf?id=Ab4lms…
#BSN2026 #ParkinsonsDisease #DigitalHealth
A key @aiprognosis milestone: recruitment for the AI-PMP study is now complete!
103 participants were recruited, exceeding the study target.
ai-prognosis.eu/news/ai-pmp-…
#ParkinsonsDisease #DigitalHealth
@aiprognosis at #SEEIC2026
On 16–17 September, project partner SquareDev participated in SEEIC 2026 in Niš, Serbia, showcasing its AI activities and solutions and raising awareness of the @aiprognosis project.
#ArtificialIntelligence #Innovation #HealthTech
@aiprognosis at the 2026 #MDSCongress | Days 3–5
The final days in Seoul brought more project research, including smartphone-based motor assessment, smartwatch data, AI-based progression prediction and work on prodromal Parkinson’s disease.
More below 👇
Natalia del Campo (CHUT) presented “AI-based Progression and Medication Response Prediction in Parkinson's Disease: the AI-PMP Study Protocol”, outlining the study’s proof-of-concept AI models for PD progression and medication response prediction.
@aiprognosis at the 2026 #MDSCongress
Over the first two days, team members presented work on AI-based Parkinson’s disease risk prediction and wearable-derived sleep and activity metrics in people with PD, at-risk individuals and healthy controls.
More on the posters below 👇
Eduardo de Pablo-Fernández (QMUL) presented “An artificial intelligence-based model to predict Parkinson’s disease risk: The AI-PRA study”, outlining the AI-PRA study and its proof-of-concept AI-based PD detection model.
The @aiprognosis digital health ecosystem brings together mAI-Health, mAI-Care & mAI-Insights to support Parkinson’s disease screening, disease management and clinical decision-making.
The applications have now matured into functional MVPs.
🔗 zenodo.org/records/21103398
@aiprognosis will be at the MDS International Congress 2026 in Seoul, presenting research from the project.
📅 4–8 October
🔗 mdscongress.org/
#ParkinsonsDisease #DigitalHealth
@aiprognosis researcher Sara Riggare was featured in @Being_Patient discussing self-tracking, Parkinson’s disease and the use of generative AI.
The article also highlights AI-PROGNOSIS-supported research involving 149 people with Parkinson’s.
🔗 beingpatient.com/parkinsons-…
From chess matches to healthcare research. ♟️🤖
Over 70 years, AI has evolved from early experiments to applications across everyday life and research.
In @aiprognosis, AI is being investigated in Parkinson’s disease research, including risk, progression and medication response.























